ERBB2 and breast cancer: Mawatari et al. [167] suggested that the valproic acid-induced cell cycle arrest and apoptosis in HER2-overexpressing breast cancer SKBR3 cells are due to the increase in acetylation of HSP70 that inactivates the chaperone and disrupts its cooperation with HSP90.